Expanding Veterans’ Access to Emerging Treatments Act

This bill establishes a Veterans Affairs research program to test innovative treatments for veterans with specific conditions like PTSD, chronic pain, and substance use disorders. It authorizes the VA to conduct clinical trials and create compassionate access protocols for emerging therapies, including ketamine, psilocybin, and other treatments listed in the bill. Veterans diagnosed with covered conditions would be eligible to participate in these trials or access approved treatments through VA-administered pathways. The program requires a report to Congress within one year detailing trial outcomes and treatment options.